OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
Dan-Yun Ruan, Furong Liu, Xiao-Li Wei, et al.
The Lancet Oncology (2025)
Closed Access | Times Cited: 2
Dan-Yun Ruan, Furong Liu, Xiao-Li Wei, et al.
The Lancet Oncology (2025)
Closed Access | Times Cited: 2
Modulating the gut microbiota: A novel perspective in colorectal cancer treatment
Xue Bai, Boyang Liu, Daiming Fan, et al.
Cancer Letters (2025), pp. 217459-217459
Closed Access
Xue Bai, Boyang Liu, Daiming Fan, et al.
Cancer Letters (2025), pp. 217459-217459
Closed Access
Identification and validation VAT1 in gastric cancer through bioinformatics and experimental analysis
Yongli Hu, Yan Du, Zhisheng Qiu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114047-114047
Closed Access
Yongli Hu, Yan Du, Zhisheng Qiu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114047-114047
Closed Access
Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy
Jiao Xu, Bixin Yu, Fan Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Jiao Xu, Bixin Yu, Fan Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Effects of 68Ga-labeled PEG and non-PEG variant peptides as HER2-targeting probes on the progression of gastrointestinal (GI) tumor cells
Xiang Ji, Han Yan, Xiang Li, et al.
Molecular & Cellular Toxicology (2024)
Closed Access
Xiang Ji, Han Yan, Xiang Li, et al.
Molecular & Cellular Toxicology (2024)
Closed Access
mRNA vaccines for gastrointestinal malignancies: cutting-edge advances and future perspectives
Gang Zhang, Xing Huang, Tingbo Liang
Science Bulletin (2024)
Closed Access
Gang Zhang, Xing Huang, Tingbo Liang
Science Bulletin (2024)
Closed Access
FBXW7 in gastrointestinal cancers: from molecular mechanisms to therapeutic prospects
Wanqing Wang, Xue Liu, Lingling Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Wanqing Wang, Xue Liu, Lingling Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
